| Literature DB >> 15219520 |
Kengo Tanabe1, Angela Hoye, Pedro A Lemos, Jiro Aoki, Chourmouzios A Arampatzis, Francesco Saia, Chi-hang Lee, Muzzafer Degertekin, Sjoerd H Hofma, Georgios Sianos, Eugene McFadden, Pieter C Smits, Willem J van der Giessen, Pim de Feyter, Ron T van Domburg, Patrick W Serruys.
Abstract
The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15219520 DOI： 10.1016/j.amjcard.2004.03.040
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778